<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-vaccines-08-00038">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Samai</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Seward</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Goldstein</surname>
    <given-names>S.T.</given-names>
   </name>
   <name>
    <surname>Mahon</surname>
    <given-names>B.E.</given-names>
   </name>
   <name>
    <surname>Lisk</surname>
    <given-names>D.R.</given-names>
   </name>
   <name>
    <surname>Widdowson</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Jalloh</surname>
    <given-names>M.I.</given-names>
   </name>
   <name>
    <surname>Schrag</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Idriss</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Carter</surname>
    <given-names>R.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The Sierra Leone trial to introduce a vaccine against Ebola: An evaluation of rVSVÎ”G-ZEBOV-GP vaccine tolerability and safety during theWest Africa Ebola outbreak</article-title>
  <source>J. Infect. Dis.</source>
  <year>2018</year>
  <volume>217</volume>
  <fpage>S6</fpage>
  <lpage>S15</lpage>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961340/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961340/</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-01-14">(accessed on 14 January 2020)</date-in-citation>
  <pub-id pub-id-type="doi">10.1093/infdis/jiy020</pub-id>
  <?supplied-pmid 29788345?>
  <pub-id pub-id-type="pmid">29788345</pub-id>
 </element-citation>
</ref>
